Literature DB >> 2780050

Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines.

P N Tonin1, H Yeger, R L Stallings, P R Srinivasan, W H Lewis.   

Abstract

The genes for the M2 subunit of ribonucleotide reductase (RRM2), ornithine decarboxylase (ODC1), and 55,000-Daltons protein (P5), are amplified in hydroxyurea-resistant hamster and human cell lines. These genomic sequences have been mapped to hamster chromosome 7 and to human chromosome 2p24-25 near the cytogenetic location of the N-myc gene. We now report that genomic sequences homologous to N-myc are amplified in hydroxyurea-resistant hamster lung cell line, 600H, and the N-myc gene segregates with hamster chromosome 7 in mouse-hamster somatic cell hybrids. The conserved linkage group consisting of the RRM2, ODC1, P5, and N-myc in the hamster and human genomes prompted our investigation of human neuroblastomas. We report here that genomic DNA from 1 of 6 primary neuroblastoma tumors containing amplified N-myc also contains amplified sequences homologous to a hamster ODC cDNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780050

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

Review 1.  Polyamine synthesis as a target of MYC oncogenes.

Authors:  André S Bachmann; Dirk Geerts
Journal:  J Biol Chem       Date:  2018-11-07       Impact factor: 5.157

2.  Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.

Authors:  M Auvinen; A Paasinen-Sohns; H Hirai; L C Andersson; E Hölttä
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

3.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.

Authors:  Sudhir Kumar Rai; Fernando Bril; Heather M Hatch; Yiling Xu; Laura Shelton; Srilaxmi Kalavalapalli; Arielle Click; Douglas Lee; Chris Beecher; Austin Kirby; Kimi Kong; Jose Trevino; Abhishek Jha; Shashank Jatav; Kriti Kriti; Soumya Luthra; Timothy J Garrett; Joy Guingab-Cagmat; Daniel Plant; Prodip Bose; Kenneth Cusi; Robert A Hromas; Arthur S Tischler; James F Powers; Priyanka Gupta; James Bibb; Felix Beuschlein; Mercedes Robledo; Bruna Calsina; Henri Timmers; David Taieb; Matthias Kroiss; Susan Richter; Katharina Langton; Graeme Eisenhofer; Raymond Bergeron; Karel Pacak; Sergei G Tevosian; Hans K Ghayee
Journal:  Metabolism       Date:  2020-06-18       Impact factor: 13.934

5.  cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.

Authors:  Qing-Rong Chen; Sven Bilke; Jun S Wei; Craig C Whiteford; Nicola Cenacchi; Alexei L Krasnoselsky; Braden T Greer; Chang-Gue Son; Frank Westermann; Frank Berthold; Manfred Schwab; Daniel Catchpoole; Javed Khan
Journal:  BMC Genomics       Date:  2004-09-20       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.